Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mescaline Sodium vs Morte-mescaline in Adult Lupus Nephritis
NCT05933213Phase 4Not yet recruiting
- Sponsor
- Xiangya Hospital, Central South University
- Start
- Jul 2023
- Primary completion
- Jul 2025
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of mycophenolate sodium in lupus nephritis (LN), sponsored by Xiangya Hospital, Central South University. Planned start Jul 2023; status: not yet recruiting.
02
Drugs
mycophenolate sodium
03
Conditions
lupus nephritis (LN)
Beyond the preview
Go deeper on NCT05933213.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05933213.